U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056309) titled 'A Study of Remternetug (LY3372993) in Healthy Participants' on June 24.
Brief Summary: The main purpose of this study is to evaluate to different formulations of remternetug after single subcutaneous (SC) administration with either an autoinjector (AI) or a prefilled syringe (PFS). The study will look at the amount of remternetug that gets into the bloodstream and how long it takes the body to get rid of the remternetug when given as two different formulations.
Participation in the study will last approximately 155 days.
Study Start Date: June 24
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Remternetug (T...